This website is intended for healthcare professionals only

Trending Topic

Close-up of a person rubbing their temple, depicting persistent headache pain
13 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Migraines profoundly impact well-being, especially in children and adolescents. From 1990 to 2021, global pediatric migraine disability has increased, with particular vulnerability in females and adolescents aged 15–19.1 A 2023 meta-analysis found the prevalence of primary headache diagnosis in individuals aged 8–18 years to be 62%.2 The prevalence of a migraine diagnosis was 11%; 8% […]

Elon Eisenberg, EAN 2023: Clinician-based indications for cannabis-based medicine in patients with neuropathic pain

8 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 19th 2023

Prof. Elon Eisenberg (Tachnion – Israel Institute of Technology, Haifa, Israel) summarizes our current knowledge on using cannabis in pain medicine, and the unmet needs in this field. He then provides some practical advice on using cannabis in clinical practice and offers his perspective on the next steps and what further studies are required.

The abstract ‘Cannabis-based medicine. Current evidence and clinician-based indications in patients with neuropathic pain’ was presented at the annual European Academy of Neurology (EAN), July 1–4, 2023

Questions

1. What are the current unmet needs in the treatment of patients with neuropathic pain? (00:20)2. Please summarize the current knowledge we have on the use of cannabis in medicine? (01:56)3. What were the key take-home messages and practical advice from your presentation on this topic at the EAN 2023 annual meeting? (03:37)
4. What are the next steps, and further studies required in this field? (07:38)

Disclosures: Elon Eisenberg is a consultant for Cannabotech; he has received grant/research support from Israel Pain Association, Rafa Laboratories, Syqe Medical and Teva Israel; he is a member of the Advisory Board for Rafa Laboratories, Syqe Medical and Vectura Ferin Pharma, and has received honoraria/honorarium from Rafa Laboratories and Syqe Medical.

Support: Interview and filming was supported by Touch Medical Media. The interview was conducted by Sophie Nickelson.

Filmed as highlight of EAN 2023.

Click here for more content in neuropathic pain

 

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup